Hospices civils de Lyon

Bron 69677

5 studies enrolling now · 10 studies all time

What they study most

Acromegaly, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors, Breast Cancer, Cholangiocarcinoma, Contrast Enhancement in Magnetic Resonance Imaging, Coronary Artery Disease, GRIN-related Neurodevelopmental Disorder, Gastric Cancer, Hemophilia A, Neuroendocrine Tumors, Non-central Nervous System Pathology, Non-small Cell Lung Cancer

Studies at this site

• A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A — Recruiting now
• A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs — Recruiting now
• Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer — Recruiting now
• Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder — Recruiting now
• Natural History Study of Participants With Sanfilippo Syndrome Type IIIC — Recruiting now
• Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients — Running, not enrolling
• A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) — Completed
• A Study of TAS-120 in Patients With Advanced Solid Tumors — Completed
• Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly — Completed
• FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT — Completed